Spyre Therapeutics Inc <SYRE.O>: BTIG raises target price to $132 from $112
SYRE•Related News
N-able Inc <NABL.N>: RBC cuts to Sector Perform from Outperform; cuts target price to $4 from $6
NABL•
US court rules Meta, other tech firms must face thousands of lawsuits over social media addiction
META•
Chicago grains futures climb as Black Sea export risks persist
DBA•
Hims & Hers Health, Inc. <HIMS.N>: Leerink Partners raises target price to $30 from $25
HIMS•
American Financial Group, Inc. <AFG.N>: KBW Raises Target Price to $153 From $148
AFG•